%20LIMITED%2010-Jul-2008_files/image002.jpg){kind=small}
MIRA
INFORM REPORT
|
Report Date : |
10.07.2008 |
IDENTIFICATION
DETAILS
|
Name : |
SWISS PHARMACEUTICALS (PVT) LIMITED |
|
|
|
|
Registered Office : |
1st Floor, Mehran Chambers, Medicine Street No. 2, Marriot
Road, Karachi |
|
|
|
|
Country : |
Pakistan |
|
|
|
|
Date of Incorporation : |
1991 |
|
|
|
|
Com. Reg. No.: |
0023264 |
|
|
|
|
Legal Form : |
Private Limited
Company |
|
|
|
|
Line of Business : |
Manufacture and Marketing of Pharmaceutical Products |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
Business Name
SWISS PHARMACEUTICALS (PVT) LIMITED
Full Address
Registered
Address
|
|
1st Floor, Mehran Chambers, Medicine Street No. 2, Marriot
Road, Karachi, Pakistan |
|
Tel |
92 (21) 2431004, 2438911,
2436287 |
|
Fax |
92 (21) 2413935 |
|
Email |
Short Description Of Business
|
Nature of Business |
Manufacture & Marketing of
Pharmaceutical Products |
|
Year Established |
1991 |
|
Registration # |
0023264 |
Factory Location
Plot No. A-159, North Karachi
Scheme No.33, Karachi, Pakistan
Auditors
M. Saleem Associates
(Chartered Accountants)
401, Land Mark Plaza,
Mohammad Bin Qasim Road, Karachi, Pakistan
Legal Status
Subject Company was
established as a Private Limited Company in 1991
|
Authorized Capital |
Rs. 15,000,000/- divided into 150,000 shares of Rs. 100/- each |
|
Issued & Paid
up Capital |
Rs. 4,800,000/- divided into 48,000 shares of Rs. 100/- each |
Details of Chief Executive/
Directors
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr. Muhammad Farooq Miss. Sadaf Miss Shabana Miss Shahina |
Pakistani Pakistani Pakistani Pakistani |
1st
Floor, Mehran Chambers, Medicine Street No. 2, Marriot Road, Karachi 1st
Floor, Mehran Chambers, Medicine Street No. 2, Marriot Road, Karachi 1st Floor,
Mehran Chambers, Medicine Street No. 2, Marriot Road, Karachi 1st
Floor, Mehran Chambers, Medicine Street No. 2, Marriot Road, Karachi |
Business Business Business Business |
Chief Executive Director Director Director |
Shareholders
|
Names |
No. of Shares |
|
Mr. Muhammad Farooq Miss. Sadaf Miss Shabana Miss Shahina |
12,000 12,000 12,000 12,000 |
Associates
A. Subsidiary
None
B. Associated Companies
Mehran Traders,
Pakistan.
Mehran
International, Pakistan.
Products / Services
Manufacture &
Marketing of Pharmaceutical Products by its brand names of ALAMCID,
AMOXICILLIN, AMPICILLIN, ARTHROX, ATOXAN, BACTOCEF, BACXIME, BLEOMYCIN, BV-CLAR,
CHLOROQUINE, CIPROK, CORCONT, CRUCIR, DERMODIC, DERMODIC-B, DEXA N, DIADYNAM-G,
DIAGYL, DISPIDINE, DOLIUM, DOXYCYCLINE, ERYSIN, FAMULCER, FEVAMOL, GLUKIL,
GLUMET, LINCOMYCIN, LOVACOR, MECOMIDE, MEFOMIDE, MEGACLOX, NEOMYCIN,
OXYTETRACYCLINE, PENTALLIN, PHENTON-S, PULMOFLOX, SANAMIDOL, SEFEXIN, SMATRIM,
SPAQUINE, SPAZOLE, STRACEF, SUDOMIN, SWIGEN, SWISO, SWISSPIME, TOBRACIN,
TRAMACIN, UTRAMAX, VINCRISTINE, VITAGLOBIN
Number of Employees
130
Trade Suppliers (Foreign)
Various International belongs to India, China & Europe
Annual Production Volume
The capacity and
production of the company’s plant is indeterminable as it involves varying
processes of manufacture.
Annual Sales Volume
|
Year |
In Pak Rupees |
|
2006 |
150,000,000/- (Estimated) |
Authorized Distributors
Mainly in all major cities of Pakistan
Bankers
Habib Bank Limited,
Pakistan.
MCB Bank Limited,
Pakistan.
Habib Metropolitan
Bank Limited, Pakistan.
Faysal Bank Limited,
Pakistan.
Memberships
·
Karachi Chamber
of Commerce & Industry (KCCI)
·
Pakistan Pharmaceutical Manufacturers Association (PPMA)
Foreign Exchange Rates
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 71.00 |
|
UK Pound |
1 |
Rs. 139.00 |
|
Euro |
1 |
Rs. 110.60 |
1
Comments
Subject Company was established in 1991 and is engaged in manufacture
& marketing of Pharmaceutical Products. Market reputation is good. Trade
relations are reported as fair. The Company can be considered for normal business
dealings at usual trade terms & conditions.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.43.16 |
|
UK Pound |
1 |
Rs.85.51 |
|
Euro |
1 |
Rs.67.95 |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)